MedPlus subsidiary faces temporary drug license suspension, minor revenue loss

MedPlus Health Services Limited announced on November 27, 2025, that its subsidiary, Optival Health Solutions Private Limited, received a two-day suspension order for a drug license. The suspension pertains to a store located at Medchal Aphb Colony, Telangana. The order was received on November 26, 2025, from the assistant director, Drugs Control Administration, Medchal, Telangana.

The suspension was issued under Rule 65 of the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. MedPlus Health Services estimates a potential revenue loss of approximately Rs1.31 lacs due to this incident.

The company confirmed that the details of this update are available on its website, www.medplusindia.com, as well as on the websites of BSE Limited and National Stock Exchange of India Ltd. Manoj Kumar Srivastava, company secretary & compliance officer, signed the announcement.